Dogs with narcolepsy helped scientists uncover orexin's role in wakefulness.
They published'Every time it gets excited — boom — it collapses': How dogs with narcolepsy helped scientists understand the disorder
First reportLive Science · 11 Sept, 09:00Z
Latest reportLive Science · 11 Sept, 09:00Z
Span0 hours · two reports
Base — every candidate starts here5
Public-interest topic (politics, world, science, health…)+1
Public-interest terms in the text (courts, tariffs, ceasefire…)+1.25
High-reliability source boost+0.75
Significance8
Deterministic and identical for every story — no engagement signals, no personalization of the score.
Why it matters
What
Live Science reports that narcoleptic dogs helped two independent teams identify orexin’s key role in wakefulness in 1999.
Why
The finding built on Masashi Yanagisawa’s earlier work and clinical observations, enabling new insomnia and narcolepsy drugs.
Watch
Live Science’s interview with Emmanuel Mignot details the dog studies, including work with his dog Watson, and orexin’s medical impact.
Where the coverage comes from
Perspective mix: 1 center.
Lean and credibility are curated v1 mappings from public ratings (AllSides / MBFC); unknown outlets stay unrated, never guessed. How outlets are rated →
How it unfolded — every article
Summary
- Live Science interviews Dr. Emmanuel Mignot, Stanford narcolepsy expert and Lasker Award co-winner.
- In 1999, orexin was identified as a key factor in wakefulness by two independent teams.
- Mignot studied narcoleptic dogs, including his own Watson, to explore orexin's function.
- The Orexin discovery led to new drugs for insomnia and narcolepsy.
- Stanford's research built on prior work from Dr. Masashi Yanagisawa and clinical observations of narcolepsy.